Milestone Pharmaceuticals (MIST) Interest Coverage Ratio (2018 - 2021)
Milestone Pharmaceuticals (MIST) posted Interest Coverage Ratio of 0.32 for Q4 2021, up 99.88% on a QoQ basis from 257.71 in Q4 2020, and up 99.88% year-over-year from 0.16 in Q4 2020.
Milestone Pharmaceuticals (MIST) Interest Coverage Ratio (2018 - 2021) Analysis & Trends
Milestone Pharmaceuticals' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 0.32 for Q4 2021.
- Quarterly Interest Coverage Ratio rose 99.88% year-over-year to 0.32 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was 0.8 (up 99.95% YoY) and the FY2021 annual result came in at 0.8, up 81.27% from the prior year.
- Interest Coverage Ratio was 0.32 for Q4 2021 at Milestone Pharmaceuticals, up from 257.71 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.32 in Q4 2021 and bottomed at 1717.45 in Q4 2019.
- A 4-year average of 418.12 and a median of 191.81 in 2020 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2019 — Interest Coverage Ratio sank 256.85% — and 2021, when it soared 99.88%.
- Milestone Pharmaceuticals' Interest Coverage Ratio stood at 481.29 in 2018, then sank by 256.85% to 1717.45 in 2019, then soared by 84.99% to 257.71 in 2020, then surged by 99.88% to 0.32 in 2021.
- Business Quant data shows MIST's Interest Coverage Ratio at 0.32 in Q4 2021, 257.71 in Q4 2020, and 97.46 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -0.32 |
| Dec 31, 2020 | -257.71 |
| Sep 30, 2020 | -97.46 |
| Dec 31, 2019 | -1,717.45 |
| Sep 30, 2019 | -125.92 |
| Jun 30, 2019 | -57.57 |
| Mar 31, 2019 | -607.22 |
| Dec 31, 2018 | -481.29 |